Characterization of Epstein-Barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with X-linked lymphoproliferative syndrome type 1 and type 2.
about
Humanized mouse models of epstein-barr virus infection and associated diseases.Modeling EBV infection and pathogenesis in new-generation humanized mice.Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens.Lymphoproliferative disorders in immunocompromised individuals and therapeutic antibodies for treatment.Advances in understanding the pathogenesis of HLH.Encephalitis treatment - a case report with long-term follow-up of EBV PCR in cerebrospinal fluid.
P2860
Characterization of Epstein-Barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with X-linked lymphoproliferative syndrome type 1 and type 2.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Characterization of Epstein-Ba ...... ve syndrome type 1 and type 2.
@ast
Characterization of Epstein-Ba ...... ve syndrome type 1 and type 2.
@en
type
label
Characterization of Epstein-Ba ...... ve syndrome type 1 and type 2.
@ast
Characterization of Epstein-Ba ...... ve syndrome type 1 and type 2.
@en
prefLabel
Characterization of Epstein-Ba ...... ve syndrome type 1 and type 2.
@ast
Characterization of Epstein-Ba ...... ve syndrome type 1 and type 2.
@en
P2093
P2860
P356
P1433
P1476
Characterization of Epstein-Ba ...... ive syndrome type 1 and type 2
@en
P2093
Akihiro Yachie
Fumiyo Kato
Haruka Kawashima
Hirokazu Kanegane
Ken-Ichi Imadome
Mitsuhiro Fujiwara
Naonori Nishida
Shigeyoshi Fujiwara
Taizo Wada
Toshio Miyawaki
P2860
P2888
P356
10.1186/2042-4280-3-1
P50
P577
2012-02-10T00:00:00Z
P5875
P6179
1014925717